Gordon Ens

421 total citations
17 papers, 306 citations indexed

About

Gordon Ens is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Infectious Diseases. According to data from OpenAlex, Gordon Ens has authored 17 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 3 papers in Infectious Diseases. Recurrent topics in Gordon Ens's work include Antiplatelet Therapy and Cardiovascular Diseases (6 papers), COVID-19 Clinical Research Studies (3 papers) and Lipoproteins and Cardiovascular Health (3 papers). Gordon Ens is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (6 papers), COVID-19 Clinical Research Studies (3 papers) and Lipoproteins and Cardiovascular Health (3 papers). Gordon Ens collaborates with scholars based in United States. Gordon Ens's co-authors include Sheryl G. A. Gabram, Lenworth M. Jacobs, Daniel T. Engelman, Robert W. Sugerman, Jonathan C. Goldsmith, Joseph A. Church, James D. Otvos, Satyendra Giri, Robert H. Allen and John H. Contois and has published in prestigious journals such as Circulation, Blood and Journal of the American College of Cardiology.

In The Last Decade

Gordon Ens

17 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gordon Ens United States	8	79	71	69	52	50	17	306
Angel Garciá‐Avello Spain	10	117 1.5×	44 0.6×	59 0.9×	65 1.3×	162 3.2×	20	517
R. G. J. Westendorp Netherlands	9	46 0.6×	18 0.3×	62 0.9×	81 1.6×	53 1.1×	10	356
Bas de Laat Netherlands	8	103 1.3×	23 0.3×	95 1.4×	46 0.9×	205 4.1×	13	364
Jeremy J. Gitomer United States	8	25 0.3×	23 0.3×	30 0.4×	71 1.4×	10 0.2×	9	343
Teresa Maria Caimi Italy	8	47 0.6×	13 0.2×	30 0.4×	44 0.8×	152 3.0×	11	295
Murat Güvener Türkiye	10	20 0.3×	40 0.6×	158 2.3×	190 3.7×	22 0.4×	36	508
Roberto Herklotz Switzerland	5	38 0.5×	25 0.4×	49 0.7×	53 1.0×	74 1.5×	10	402
F Pusineri Italy	7	63 0.8×	14 0.2×	72 1.0×	115 2.2×	203 4.1×	7	503
Walter E. Kelley United States	9	20 0.3×	26 0.4×	255 3.7×	81 1.6×	41 0.8×	22	490
Bente Krogsgaard Schaadt Denmark	12	70 0.9×	5 0.1×	103 1.5×	50 1.0×	17 0.3×	13	489

Countries citing papers authored by Gordon Ens

Since Specialization

Citations

This map shows the geographic impact of Gordon Ens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon Ens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon Ens more than expected).

Fields of papers citing papers by Gordon Ens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon Ens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon Ens. The network helps show where Gordon Ens may publish in the future.

Co-authorship network of co-authors of Gordon Ens

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon Ens. A scholar is included among the top collaborators of Gordon Ens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon Ens. Gordon Ens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Tantry, Udaya S., et al.. (2021). First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19. Open Forum Infectious Diseases. 8(7). ofab274–ofab274. 19 indexed citations

Gurbel, Paul A., Kevin P. Bliden, Amit Rout, et al.. (2021). Bedside thromboelastography to rapidly assess the pharmacodynamic response of anticoagulants and aspirin in COVID-19: evidence of inadequate therapy in a predominantly minority population. Journal of Thrombosis and Thrombolysis. 51(4). 902–904. 13 indexed citations

Gurbel, Paul A., et al.. (2021). IS LOW DOSE ASPIRIN EFFECTIVE IN REDUCING IN-HOSPITAL CLINICAL OUTCOMES IN PATIENTS WITH COVID-19?. Journal of the American College of Cardiology. 77(18). 3083–3083. 1 indexed citations

Singla, Anand, Kevin P. Bliden, Udaya S. Tantry, et al.. (2012). Abstract 15997: First Report of a Dose Dependent Effect of Statin Therapy on Urinary 11-dehydrothromboxane Br2 rLevels: A New Marker for Personalizing Statin Therapy. Circulation. 126. 1 indexed citations

Singla, Anand, Kevin P. Bliden, Peter P. Tóth, et al.. (2012). TCT-715 First Demonstration of dose Dependent Effect of Statin Therapy on Urinary 11-dehydrothromboxane B2 levels in Patients Undergoing Coronary Angiography. Journal of the American College of Cardiology. 60(17). B208–B208. 1 indexed citations

Geske, F. Jon, Kirk E. Guyer, & Gordon Ens. (2008). Aspirin Works®. Molecular Diagnosis & Therapy. 12(1). 51–54. 8 indexed citations

Geske, F. Jon, et al.. (2005). A New and Rapid Immunoassay for the Detection of 11-Dehydro-Thromboxane B2.. Blood. 106(11). 2641–2641. 1 indexed citations

Schwartz, Kenneth A., et al.. (2002). A new method for measuring inhibition of platelet function by nonsteroidal antiinflammatory drugs. Journal of Laboratory and Clinical Medicine. 139(4). 227–233. 16 indexed citations

Mielke, C. Harold, Christopher M. Starr, John Klock, et al.. (1999). Direct Measurement of Unfractionated Heparin Using a Biochemical Assay. Clinical and Applied Thrombosis/Hemostasis. 5(4). 267–276. 2 indexed citations

10.

Giri, Satyendra, Paul D. Thompson, John H. Contois, et al.. (1998). Oral estrogen improves serum lipids, homocysteine and fibrinolysis in elderly men. Atherosclerosis. 137(2). 359–366. 81 indexed citations

11.

Jensen, Roderick V. & Gordon Ens. (1997). Resistance to activated protein C: a major cause of inherited thrombophilia.. PubMed. 10(4). 219–22. 4 indexed citations

12.

Sugerman, Robert W., Joseph A. Church, Jonathan C. Goldsmith, & Gordon Ens. (1996). Acquired protein S deficiency in children infected with human immunodeficiency virus. The Pediatric Infectious Disease Journal. 15(2). 106–111. 40 indexed citations

13.

Engelman, Daniel T., et al.. (1996). Hypercoagulability following Multiple Trauma. World Journal of Surgery. 20(1). 5–10. 100 indexed citations

14.

Hormes, Joseph T., James H. Austin, Don B. Smith, et al.. (1991). Toward an optimal “antiplatelet” dose of aspirin: Preliminary observations. Journal of Stroke and Cerebrovascular Diseases. 1(1). 27–35. 10 indexed citations

15.

McCormick, James G., et al.. (1978). AC cochlear potentials in an animal model for human atherosclerosis: Relationships to blood pressure, vascular disease, and blood coagulation. The Journal of the Acoustical Society of America. 64(S1). S133–S133. 1 indexed citations

16.

McCormick, James G., et al.. (1977). Cochlear potentials of the pigeon: relationships to age, serum cholesterol level, atherosclerosis, and blood coagulation factors. The Journal of the Acoustical Society of America. 61(S1). S26–S27. 1 indexed citations

17.

Kaulla, Kurt N. von & Gordon Ens. (1967). On structure-related properties of synthetic organic clot-dissolving (thrombolytic) compounds. Biochemical Pharmacology. 16(6). 1023–1034. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact